Welcome 🤝 Elizabeth Lensmith and Maxim Voropaiev! 🎉
The Opterion team is happy ✨ to have you on board.
Elizabeth supports us as Scientific/Technical Project Support Associate. She holds a master’s degree (MSc) in Pharmatechnology and Drug Manufacturing. With her background in drug analysis, she is a great addition to our team. 💎
Opterion’s new Chief Medical Officer is Maxim Voropaiev. He holds a Medical Doctor (MD) 🩺 degree and a master’s degree (MAS) in statistics. With his many years of experience in the pharmaceutical industry and in multiple therapeutic areas, Maxim has built a unique set of skills geared towards the excellence in clinical studies design and execution.
Both new colleagues will play a key role in Opterion’s next development steps to bring our novel peritoneal dialysis (PD) solution, which has the potential to improve the quality of life of many patients, into the clinic and ultimately to the market.